Controlled early access
Founding Clinician Access
An early-access programme for registered psychologists who want to evaluate nou CRD and provide structured product feedback. Access remains controlled while the clinical and product audit is in progress.
Programme outline
- CRD access for 12 months when live access is issued
- Proposed founding-year price: £499; proposed standard annual price thereafter: £750
- Priority feedback channel and visibility of planned product work
These prices describe the planned programme; this page is not a live purchase offer while billing remains in test or unconfirmed mode.
Boundaries
- Not equity, ownership, or voting rights
- Not autonomous diagnosis, treatment selection, triage, or crisis care
- Not a substitute for professional judgement, supervision, or local policy
- Regulatory classification of the final intended purpose remains under assessment; this page does not assert medical-device status either way
Nou may use a configured AI model only to pressure-test substantive clinician-authored reasoning. It does not originate the formulation, 5P, diagnosis, treatment plan, triage decision, risk classification, or crisis response. Model output is provisional, policy-checked, and discarded if it crosses Nou's clinical output boundary. The clinician remains responsible for the record and every clinical decision.
Professional attestation & access
When live billing is enabled, payment is processed by Stripe. Continuing to a live checkout means you agree to the Terms of use and Privacy notice.
Planned soft limit: 50 founding places. Questions: hello@thenou.app.